Extended Postinterventional Tumor Necrosis-Implication for Outcome in Liver Transplant Patients with Advanced HCC

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kornberg, Arno ^a   Witt, Ulrike ^a   Matevossian, Edouard ^a   Küpper, Bernadett ^b   Aßfalg, Volker ^a   Drzezga, Alexander ^c   Hüser, Norbert ^a   Wildgruber, Moritz ^c   Friess, Helmut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Department of Surgery   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; IODINATED POPPYSEED OIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; EXTENDED POSTINTERVENTIONAL TUMOR NECROSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERVENTIONAL BRIDGING THERAPY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR NECROSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872806419     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053960     Document Type: Article

References (41)

1. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE, (1985) Role of liver transplantation in cancer therapy. Ann Surg 202: 401-407.
2. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R, (1988) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207: 373-379.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 14; 334: 693-699.
4. Bhoori S, Sposito C, Germini A, Coppa J, Mazzaferro V, (2010) The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transpl Int 23: 712-722.
5. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, et al. (2008) Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 15: 1001-1007.
6. Massie AB, Caffo B, Gentry SE, Hall EC, Axelrod DA, et al. (2011) MELD Exceptions and Rates of Waiting List Outcomes. Am J Transplant 11: 2362-2371.
7. Facciuto ME, Singh MK, Katta U, Samaniego S, Sharma J, et al. (2011) Liver transplantation for hepatocellular carcinoma: defining the impact of using extended criteria liver allografts. Transplantation 92: 446-452.
8. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology; 33: 1394-1403.
9. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, et al. (2008) Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 48: 819-827.
10. Schlitt HJ, Schnitzbauer AA, (2011) Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment. Liver Transpl 17 Suppl 3: S10-12.
11. Loffroy R, (2011) Interventional radiology for hepatocellular carcinoma. Minerva Gastroenterol Dietol 57: 299-309.
12. Lubienski A, (2005) Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 80: S113-119.
13. Otto G, Herber S, Heise M, Lohse AW, Mönch C, et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12: 1260-1267.
14. Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, et al. (2008) Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 248: 617-625.
15. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, et al. (2008) Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 8: 2547-2557.
16. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, et al. (2012) OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13: e11-22.
17. Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, et al. (2011) Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 53: 1580-1589.
18. Kornberg A, Küpper B, Thrum K, Katenkamp K, Steenbeck J, et al. (2009) Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients. Transplant Proc 41: 2561-2563.
19. Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, et al. (2009) Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50: 682-687.
20. Kornberg A, Küpper B, Thrum K, Wilberg J, Sappler A, et al. (2009) Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET. Am J Transplant 9: 2631-2636.
21. Gadaleta CD, Ranieri G, (2011) Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Crit Rev Oncol Hematol 80: 40-53.
22. Minami Y, Kudo M, (2011) Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol.; 17: 4952-4959.
23. Tiong L, Maddern GJ, (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98: 1210-1224.
24. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, et al. (1997) Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688-701.
25. Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA, (2006) Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 6: 2644-2650.
26. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, et al. (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 11: 767-775.
27. Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, et al. (2004) Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 10: 449-455.
28. Schwartz ME, D'Amico F, Vitale A, Emre S, Cillo U, (2008) Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid? Eur J Surg Oncol 34: 256-262.
29. Silva MF, Sherman M, (2011) Criteria for liver transplantation for HCC: what should the limits be? J Hepatol 55: 1137-1147.
30. Kornberg A, Küpper B, Tannapfel A, Büchler P, Krause B, et al. (2012) Patients with non-[18F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation. Liver Transpl 18: 53-61.
31. Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, et al. (2009) Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis. Clin Transplant 23, Suppl 21: 61-67.
32. Wong LL, Tanaka K, Lau L, Komura S, (2004) Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant 18: 227-234.
33. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, et al. (2006) Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203: 411-420.
34. Volk ML, Vijan S, Marrero JA, (2008) A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 8: 839-46.
35. Kwan SW, Fidelman N, Ma E, Kerlan RK Jr, Yao FY, (2012) Imaging predictors of response to transarterial chemoembolization in patients with hepatocellular carcinoma: Radiologic-pathologic correlation. Liver Transpl 18: 727-736.
36. Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, et al. (2010) Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging 31: 348-355.
37. Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC, (2009) Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma. J Gastrointestin Liver Dis 18: 169-176.
38. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, et al. (2006) Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81: 1633-1639.
39. Sotiropoulos GC, Malagó M, Molmenti E, Paul A, Nadalin S, et al. (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic? Transplantation 79: 483-487.
40. Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, et al. (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 13: 272-279.
41. Henry JC, Malhotra L, Khabiri H, Guy G, Michaels A, et al. (2012) Best radiological response to trans-arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes. HPB (Oxford), published first online 26 AUG 2012.